Data / Form D filings / Naurex Inc.
Naurex Inc.: Form D filings
Naurex Inc., a pharmaceuticals company in Evanston, IL, filed 7 Form D notices with the SEC between 2009 and 2014. The latest, on December 3, 2014, reports $80 million sold of an offering with no set size to 61 investors.
Find out what Naurex Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1801 MAPLE AVENUE, SUITE 4300, Evanston, IL, 60201
- Phone
- (847) 871-0377
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1467762
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 3, 2014 | New notice | Indefinite | $79,999,999 | Indefinite | 61 | Nov 21, 2014 | sec.gov |
| May 14, 2014 | New notice | Indefinite | $24,950,507 | Indefinite | 40 | May 1, 2014 | sec.gov |
| Dec 21, 2012 | New notice | $37,997,768 | $37,997,768 | $0 | 31 | Dec 12, 2012 | sec.gov |
| May 19, 2011 | New notice | Indefinite | $10,959,862 | Indefinite | 43 | May 9, 2011 | sec.gov |
| Feb 4, 2011 | Amendment | Indefinite | $1,106,600 | Indefinite | 24 | Jun 24, 2009 | sec.gov |
| Mar 23, 2010 | Amendment | $875,000 | $736,600 | $138,400 | 18 | Jun 24, 2009 | sec.gov |
| Jul 8, 2009 | New notice | $625,000 | $200,000 | $425,000 | 4 | Jun 24, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth J. Widder | Director | |
| Terry P. Gould | Director | |
| Robert J. Hombach | Director | |
| Mitchell S. Bloom | Executive Officer | |
| Wilbur H. Gantz | Director | |
| Norbert G. Riedel | Executive Officer, Director | |
| Ashish M. Khanna | Executive Officer | |
| Ronald M. Burch | Executive Officer | |
| Mohamed Amin Khan | Executive Officer | |
| Derek A. Small | Director | |
| James M. Schulz | Executive Officer | |
| Ian R. Ferrier | Director | |
| Joseph R. Moskal | Executive Officer |
Every Form D from the week of Dec 1, 2014 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Naurex Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.